UPDATE: Children ages 5-11 are now eligible for the Pfizer-BioNTech COVID-19 vaccine, after the director of the CDC signed off Tuesday night on an expert panel’s recommendation. Children in this age group could begin getting shots as soon as this week. Previously the FDA authorized the shots for children ages 5-11. ORIGINAL: A key federal advisory committee unanimously recommended Tuesday that kids ages 5 to 11 receive Pfizer-BioNTech's COVID-19 vaccine, setting the stage for mass vaccination of America's elementary school children. Children in this age group could begin getting shots as soon as this week, once the director of the Centers for Disease Control and Prevention signs off, as expected. Presidential advisor Jeffrey Zients said Monday that the Biden administration has ordered enough vaccines to cover all 28 million American children in the age group. The administration’s distribution program will be “running at full strength” the week of Nov. 8, he said. While the vaccines carry some risk for children, their benefits are greater, concluded the CDC's Advisory Committee on Immunization Practices, made up of vaccine and immune system experts from universities and medical schools across the country. key federal advisory committee unanimously recommended Tuesday that kids ages 5 to 11 receive Pfizer-BioNTech's COVID-19 vaccine, setting the stage for mass vaccination of America's elementary school children. Children in this age group could begin getting shots as soon as this week, once the director of the Centers for Disease Control and Prevention signs off, as expected. Presidential advisor Jeffrey Zients said Monday that the Biden administration has ordered enough vaccines to cover all 28 million American children in the age group. The administration’s distribution program will be “running at full strength” the week of Nov. 8, he said. While the vaccines carry some risk for children, their benefits are greater, concluded the CDC's Advisory Committee on Immunization Practices, made up of vacci